Reply to 'A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine'

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e141-e142. doi: 10.1111/jdv.18646. Epub 2022 Oct 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • ChAdOx1 nCoV-19
  • Humans
  • Pityriasis Lichenoides*

Substances

  • ChAdOx1 nCoV-19
  • COVID-19 Vaccines